Description
Mass spectrometry generally exists at the frontier of analytical measurement capabilities, continually driving innovation and growth for sensitive quantitative and qualitative laboratory testing worldwide. As noted in SDi’s coverage of the technology in the 2019 Global Assessment Report, its growth in the marketplace is primarily being driven by demand from pharmaceuticals, foods, and environmental testing labs. Over the past decade, however, robust increases in demand from hospital and clinical labs have proven to be one of the technology’s greatest drivers. Moreover, there has been an explosion of mass spec sales in the world of in vitro diagnostics following the FDA clearance and CE-marking of select models and assays over the past few years.
SDi’s latest publication, the 2019 Mass Spectrometry Market for Clinical Applications, provides in-depth market data on the burgeoning clinical market for mass spectrometry. Produced in collaboration with Kalorama Information, the report steps into the world of both clinical research and clinical diagnostics labs, looking at how the technology has been implemented into application areas such as toxicology, therapeutic drug monitoring, microbial identification, vitamin D quantitation, newborn screening, and more.
The report contains market size, five-year growth rate, vendor share, and commentary for select mass spec technologies in the clinical market, including GC/MS, LC/MS-MS, Q-TOF LC/MS, FT/MS & Ion Trap, and ICP-MS. For the overall market, demand by region and application category is also included. The report also contains news timelines for IVD approvals of mass spec products, new system introductions, and supplier collaborations. An updated list of select clinical MS products in the marketplace is included as well.
Objectives of this Report
- A global landscape and trends of the use of mass spectrometry techniques in clinical applications, including approved IVD and CE-marked tests, LDTs, and relevant RUO usage in a clinical setting.
- Market demand and growth by technology and product type.
- Technology breakdown for mass spec techniques used in clinical applications. The report includes: gas chromatography/mass spectrometry, MALDI-TOF, LC/MS-MS, Q-TOF LC/MS, FT/MS & Ion-Trap LC/MS, and inductively coupled plasma mass spectrometry.
- Vendor share by technique.
- Competitive landscape of vendors participating in each technology.
- Timelines of relevant IVD product approvals over the past 15 years, and more recent news items for product introductions and vendor technology collaborations.
Companies profiled:
- Advion
- Agena Bioscience
- Agilent
- Analytik Jena
- Beckman Coulter (Danaher)
- bioMérieux
- Bruker
- JEOL
- PerkinElmer
- Scientific Analysis Instruments
- SCIEX (Danaher)
- Shimadzu
- Thermo Fisher Scientific
- Waters
Table of Contents
Introduction
- About This Report
- Executive Summary
- Definitions & Methodology
Technology Overview
- Overview of Mass Spec Technology
- Common Ionization Techniques for Clinical MS
- Mass Analyzers
- Hyphenated Techniques
Background on Clinical MS
- Mass Spectrometry in the Clinical Lab
- Common Applications of Clinical Mass Spectrometry
- Laboratory Developed Tests (LDT) in Mass Spectrometry
- in vitro Diagnostics (IVD) with Mass Spectrometry
Market Demand
- Overall Clinical MS
- Clinical MS Market vs. Overall Benchtop MS Market (2018)
- Market Demand by Clinical MS Product Type (2018 – 2023)
- Market Demand by Clinical Application Category (2018)
- Vendor Participation by Clinical MS Technique (2018)
- Market Share by Company (2018)
- Market Demand by Region (2018 – 2023)
- Clinical GC/MS
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
- Clinical MALDI-TOF
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
- Clinical LDT/RUO Market vs Clinical IVD Market (2018)
- Clinical LC/MS-MS
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
- Clinical LDT/RUO Market vs Clinical IVD Market (2018)
- Clinical Q-TOF LC/MS
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
- Clinical FT/MS & Ion-Trap LC/MS
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
- Clinical ICP-MS
- Market Demand by Product Type (2018 – 2023)
- Market Share by Company (2018)
Market Developments
- Timeline for Clinical IVD MS Product Approvals (2004 – Aug 2019)
- Recent System Introductions (Jan 2017 – Aug 2019)
- Timeline for Supplier Company Collaborations (Jan 2017 – Aug 2019)
Appendix
- Select List of Clinical MS Technologies
- Recent & Upcoming Reports from SDi
